TrialFuture oncology (London, England)2019

GENESIS: Phase III trial evaluating BL-8040 + G-CSF to mobilize hematopoietic cells for autologous transplant in myeloma.

Zachary D Crees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.